● Recruiting

Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

Condition: nAMD · Sponsor: Sinocelltech Ltd.

PhasePhase 1/Phase 2

Planned participants82

Who can joinAll sexes, 45 Years to 80 Years

Healthy volunteersNo

About this study

Multicenter, open-label, multi-dose study to evaluate the safety and tolerability in patients with nAMD treated with SCT520FF.

This description comes directly from the study's public registry record.

Talk to the study team

Li Xiaorong · +86-18626789043 · 35479080@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tianjin Medical University Eye Hospital

Tianjing, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06672536